Search

everythinglearnresearchcommunity

for

Search:↓

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

PGD2 stops hair growth and is higher in bald men with AGA.

Finasteride treatment can decrease certain steroids and increase others, possibly leading to depression symptoms in some cases.

Injectable platelet-rich fibrin is better than platelet-rich plasma for promoting hair growth.

Fenoterol treatment causes increased hair growth due to higher metabolism in hair follicles, not hormones.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Topical prostaglandin analogues may improve hair density in androgenetic alopecia, but more research is needed.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Cyproterone acetate at 2mg daily is as effective as higher doses for treating excessive hair growth in women.

Combining PRF and PDO threads shows promise in treating male pattern baldness.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

Progesterone and testosterone protect brain cells from damage through specific pathways.

PRP injections are safe but don't significantly improve Peyronie's Disease.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

Hirsutism is managed by assessing testosterone levels and using oral contraceptives, with ethical considerations on treatment access.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Using travoprost for glaucoma may cause extra hair growth and darker skin around the eyes, but these effects can reverse after stopping the drug.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

Injectable platelet-rich fibrin therapy improved hair and scalp conditions in women with excessive hair loss.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.